Alpha 1 Antitrypsin Deficiency News and Research

RSS
RCSI study: Alpha-1 antitrypsin deficiency more prevalent in Ireland

RCSI study: Alpha-1 antitrypsin deficiency more prevalent in Ireland

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Isis designates ISIS-AATRx candidate in collaboration with GSK

Isis designates ISIS-AATRx candidate in collaboration with GSK

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

PPTA applauds introduction of 'Preserving Access to Orphan Drugs Act'

PPTA applauds introduction of 'Preserving Access to Orphan Drugs Act'

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

PPTA offers new DVD on plasma donation

PPTA offers new DVD on plasma donation

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Neurology professor receives MFRF's 'See the Light' award for Tay-Sachs research

Neurology professor receives MFRF's 'See the Light' award for Tay-Sachs research

Investigators receive two Alpha-1 Foundation grants for research on lung disorder

Investigators receive two Alpha-1 Foundation grants for research on lung disorder

Science and precedent do not support biosimilar approach for plasma protein therapies

Science and precedent do not support biosimilar approach for plasma protein therapies

Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal

Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal

New iPSC cell lines could help in treating patients with lung diseases

New iPSC cell lines could help in treating patients with lung diseases

Baxter announces launch of GLASSIA in the U.S.

Baxter announces launch of GLASSIA in the U.S.

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

Talecris Biotherapeutics announces 2010 eALTA award recipients

Talecris Biotherapeutics announces 2010 eALTA award recipients

FDA grants AGTC $1M for Phase II human clinical trial in alpha-1 antitrypsin deficiency

FDA grants AGTC $1M for Phase II human clinical trial in alpha-1 antitrypsin deficiency

PPTA supports CMS' proposal for hospital outpatient reimbursement for plasma protein therapies

PPTA supports CMS' proposal for hospital outpatient reimbursement for plasma protein therapies

Californians recognized for contributing to plasma protein lifesaving therapies

Californians recognized for contributing to plasma protein lifesaving therapies

Kamada, Baxter enter distribution and manufacturing agreement for Glassia Alpha-1 Antitrypsin Product

Kamada, Baxter enter distribution and manufacturing agreement for Glassia Alpha-1 Antitrypsin Product

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.